<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31672">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01769118</url>
  </required_header>
  <id_info>
    <org_study_id>0442-12</org_study_id>
    <nct_id>NCT01769118</nct_id>
  </id_info>
  <brief_title>The Influences of Caffeine on Heart Rate Variability of Preterm Infants</brief_title>
  <official_title>The Influences of Caffeine on HRV of Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Caffeine has a stimulatory effect on the ANS. This has not yet been investigated in preterm
      infant who get caffeine before stopping ventilation. The investigators hypothesis is that
      this stimulatory effect may be characterized by HRV analysis methods.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>No</safety_issue>
    <description>Heart rate, SD, SDNN, HF, LF, VLF, TP</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Autonomic Nervous System</condition>
  <arm_group>
    <arm_group_label>Caffeine</arm_group_label>
    <description>caffeine will be given according to clinical judgment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <description>Caffeine will be given according to departmental protocol</description>
    <arm_group_label>Caffeine</arm_group_label>
    <other_name>caffeine</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        25 preterm infants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infants born before 34 weeks gestation

        Exclusion Criteria:

          -  sepsis

          -  congenital malformations
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>25 Weeks</minimum_age>
    <maximum_age>34 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amir Weissman, MD</last_name>
    <phone>0502061366</phone>
    <phone_ext>972</phone_ext>
    <email>wamir@rambam.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Irena Olanovsky, MD</last_name>
    <phone>0502064799972</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>RMC</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amir Weissman, MD</last_name>
      <phone>0502061366</phone>
      <phone_ext>972</phone_ext>
      <email>wamir@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Amir Weissman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irena Olanovsky, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 15, 2013</lastchanged_date>
  <firstreceived_date>January 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>wamir</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Autonomic nervous system</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
